Inflammatory Bowel Disease
-
First! FDA approves new indication for Johnson & Johnson’s IL-23 antibody
Congratulations to Johnson & Johnson!
-
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Congratulations to Lilly and Morphic! This acquisition will expand Lilly’s immunology pipeline with oral integrin therapies
